High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

David P. Labbé(Harvard University), Giorgia Zadra(Brigham and Women's Hospital), Meng Yang(Harvard University), Jaime M. Reyes(Harvard University), Charles Y. Lin(Baylor College of Medicine), Stefano Cacciatore(International Centre for Genetic Engineering and Biotechnology), Ericka M. Ebot(Harvard University), Amanda L. Creech(Broad Institute), Francesca Giunchi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Michelangelo Fiorentino(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Habiba Elfandy(Dana-Farber Cancer Institute), Sudeepa Syamala(Dana-Farber Cancer Institute), Edward D. Karoly(Metabolon (United States)), Mohammed Alshalalfa(Decipher Biosciences (Canada)), Nicholas Erho(Decipher Biosciences (Canada)), Ashley E. Ross(Johns Hopkins University), Edward M. Schaeffer(Northwestern University), Ewan A. Gibb(Decipher Biosciences (Canada)), Mandeep Takhar(Decipher Biosciences (Canada)), Robert B. Den(Thomas Jefferson University), Jonathan Lehrer(Decipher Biosciences (Canada)), R. Jeffrey Karnes(Mayo Clinic), Stephen J. Freedland(Cedars-Sinai Medical Center), Elai Davicioni(Decipher Biosciences (Canada)), Daniel E. Spratt(University of Michigan), Leigh Ellis(Broad Institute), Jacob D. Jaffe(Broad Institute), Anthony V. D’Amico(Brigham and Women's Hospital), Philip W. Kantoff(Memorial Sloan Kettering Cancer Center), James E. Bradner(Harvard University), Lorelei A. Mucci(Brigham and Women's Hospital), Jorge E. Chavarro(Brigham and Women's Hospital), Massimo Loda(Broad Institute), Myles Brown(Harvard University)
Nature Communications
September 25, 2019
Cited by 180Open Access
Full Text

Abstract

Abstract Systemic metabolic alterations associated with increased consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality, but the molecular underpinnings of this association are poorly understood. Here, we demonstrate in a murine prostate cancer model, that high-fat diet (HFD) enhances the MYC transcriptional program through metabolic alterations that favour histone H4K20 hypomethylation at the promoter regions of MYC regulated genes, leading to increased cellular proliferation and tumour burden. Saturated fat intake (SFI) is also associated with an enhanced MYC transcriptional signature in prostate cancer patients. The SFI-induced MYC signature independently predicts prostate cancer progression and death. Finally, switching from a high-fat to a low-fat diet, attenuates the MYC transcriptional program in mice. Our findings suggest that in primary prostate cancer, dietary SFI contributes to tumour progression by mimicking MYC over expression, setting the stage for therapeutic approaches involving changes to the diet.


Related Papers

No related papers found

Powered by citation graph analysis